GlassScriptPhysician profile
Benjamin Lehman
NPI 1750912978
$2,017.32
in general payments reported to CMS, 2019-2025
17 companies · $792 in 2025
The $792 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.95 · 2022: $219 · 2023: $256 · 2024: $650 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,499 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,499.07 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $396.29 | 2021-2025 | Xtandi, Myrbetriq |
| Convatec INC. | $347.80 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $260.84 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $208.57 | 2023-2025 | |
| Urovant Sciences INC | $152.25 | 2022 | |
| Urogen Pharma, INC. | $137.30 | 2022-2025 | |
| Tolmar, INC. | $109.45 | 2023-2025 | Eligard, Rubraca, Jatenzo |
| Merck Sharp & Dohme LLC | $84.22 | 2024-2025 | Keytruda |
| Immunitybio, INC. | $78.87 | 2024-2025 | |
| Medtronic, INC. | $64.16 | 2022-2025 | Signia |
| Laborie Medical Technologies Corp. | $53.82 | 2025 | Endosheath Technology |
| Teleflex LLC | $23.39 | 2025 | Barrigel |
| Pharmaand Gmbh | $22.72 | 2025 | Rubraca |
| Cycle Pharmaceuticals INC | $22.47 | 2025 | Venxxiva |
| Janssen Biotech, INC. | $21.57 | 2025 | Erleada |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $19.22 | 2025 | Illuccix |
| Coloplast Corp | $14.38 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Lehman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.